Relmada Therapeutics Inc
NASDAQ:RLMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
L
|
Lowe's Companies Inc
SWB:LWE
|
US |
|
Quest Resource Holding Corp
F:5ZK
|
US |
Multiples-Based Value
The Multiples-Based Value for
Relmada Therapeutics Inc (RLMD) under the Base Case is 0.35 USD.
Compared with the current market price of 4.2 USD, the stock appears
Overvalued by 92% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.